Patents by Inventor Masanobu Kanou

Masanobu Kanou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENETICALLY MODIFIED MICROORGANISM AND METHOD BOTH FOR PRODUCING NICOTINAMIDE DERIVATIVE, AND VECTOR FOR USE IN SAME
    Publication number: 20220056458
    Abstract: Provided is a technique for synthesizing a nicotinamide derivative (NAm derivative) such as a nicotinamide mononucleotide (NMN) with high efficiency. A genetically modified microorganism is used, which can express, as nicotinamide phosphoribosylt ransferase (NAMPT), NAMPT having a conversion efficiency of 5-folds or more that of human NAMPT.
    Type: Application
    Filed: December 17, 2019
    Publication date: February 24, 2022
    Applicants: TEIJIN LIMITED, SYNART CO., LTD.
    Inventors: Shinichiro SHOJI, Jun ISHII, Akihiko KONDO, Hidekazu WATANABE, Masanobu KANOU, Ryota NAKAJIMA
  • 1-BIARYLAZETIDINONE DERIVATIVE
    Publication number: 20100125059
    Abstract: The object of the present invention is to provide a compound having an excellent cholesterol-lowering effect and to provide a drug for the treatment, prevention of onset, or prevention of progress of lipid metabolism disorder, hyperlipidemia, or atherosclerosis. A compound represented by formula (I) or a pharmaceutically acceptable salt thereof; or a medicament or a pharmaceutical composition, which contain the compound or the salt as an active ingredient.
    Type: Application
    Filed: March 4, 2008
    Publication date: May 20, 2010
    Applicant: Teijin Pharma Limited
    Inventors: Akira Nakano, Ryota Nakajima, Masanobu Kanou, Seiichi Hisamatsu, Masayuki Kurokawa, Yasumi Nishiwaki